In the current study, PI3K, Akt, HSP90, MYC, and p53 were identified as key targets for the treatment of hepatic fibrosis with YYHXD, and these targets were enriched in the PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and Hepatic fibrosis.